Fibroblast Growth Factor 23, Parathyroid Hormone, and 1α,25-Dihydroxyvitamin D in Surgically Treated Primary Hyperparathyroidism
Authors:
- 1 December 2004
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 79 (12) , 1508-1513
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteersKidney International, 2003
- Letters to the Editors: 2Clinical Endocrinology, 2003
- Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked HypophosphatemiaNew England Journal of Medicine, 2003
- Parathyroid hormone and dietary phosphate provoke a lysosomal routing of the proximal tubular Na/Pi-cotransporter type IIKidney International, 1998
- The effects of 1,25-dihydroxyvitamin D-3 deficiency on Ca2+-transport and Ca2+-uptake into brush-border membrane vesicles from pig small intestineBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- DEVELOPMENT OF HOMOLOGOUS IMMUNOLOGICAL ASSAYS FOR HUMAN PARATHYROID HORMONEJournal of Endocrinology, 1980
- PRIMARY HYPERPARATHYROIDISM WITH INTERMITTENT HYPERCALCAEMIA: SERIAL OBSERVATIONS AND SIMPLE DIAGNOSIS BY MEANS OF AN ORAL CALCIUM TOLERANCE TESTClinical Endocrinology, 1980
- The Importance of Circulating 1,25-Dihydroxyvitamin D in the Pathogenesis of Hypercalciuria and Renal-Stone Formation in Primary HyperparathyroidismNew England Journal of Medicine, 1980
- PRIMARY HYPERPARATHYROIDISMMedicine, 1974
- Site and control of phosphate reabsorption by the kidneyKidney International, 1973